Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Half-dose Photodynamic Therapy Versus Eplerenone in Chronic CenTRAl Serous Chorioretinopathy (SPECTRA Trial)

NCT03079141 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT03079141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03079141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Half-dose Photodynamic Therapy Versus Eplerenone in Chronic CenTRAl Serous Chorioretinopathy (SPECTRA Trial)
Lead sponsor
Leiden University Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
February 20, 2017
Completion date
August 31, 2021
Enrollment
107 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic central serous chorioretinopathy